Innovating Works

AGILENT

Desconocido
NeXED: Network for Cross disciplinary assessment of Endocrine Disrupting compounds training the next gener... AGILENT TECHNOLOGIES SALES SERVICES GMBH CO KG participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 The EU has flagged endocrine disrupting chemicals (EDCs), which interfere with normal hormonal function leading to adverse health effects, o...
2024-06-25 - 2028-12-31 | Financiado
INITIATE: INnate ImmunomeTabolIsm as Antiviral TargEt AGILENT TECHNOLOGIES SALES SERVICES GMBH CO KG participó en un H2020: H2020-MSCA-ITN-2018 Viral outbreaks and epidemics continue to impose high morbidity and mortality burdens in mankind and animals, emphasizing the urgent need fo...
2019-05-21 - 2023-04-30 | Financiado
ImPRESS: International Interdisciplinary PhD studies in Biomedical Research and Biostatistics. Supporting the... AGILENT TECHNOLOGIES SALES SERVICES GMBH CO KG participó en un H2020: H2020-MSCA-COFUND-2016 The aim of the project is to launch Interdisciplinary PhD Studies in Biomedicine aimed at young aspiring scientists, who will conduct resear...
2017-05-12 - 2023-01-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... AGILENT TECHNOLOGIES SALES SERVICES GMBH CO KG participó en un FP6: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... AGILENT TECHNOLOGIES SALES SERVICES GMBH CO KG participó en un FP7: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.